Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.

Kymes SM, Plotzke MR, Li JZ, Nichol MB, Wu J, Fain J.

Am J Ophthalmol. 2010 Jul;150(1):74-81. doi: 10.1016/j.ajo.2010.01.037. Epub 2010 May 20.

PMID:
20493465
2.

The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.

Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB.

Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14.

PMID:
19285730
3.

Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.

Gieser DK, Tracy Williams R, O'Connell W, Pasquale LR, Rosenthal BP, Walt JG, Katz LM, Siegartel LR, Wang L, Rosenblatt LC, Stern LS, Doyle JJ.

J Glaucoma. 2006 Oct;15(5):419-25.

PMID:
16988605
4.

Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.

Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R.

J Glaucoma. 2007 Sep;16(6):513-20.

PMID:
17873711
5.

Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.

Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML.

Med Care. 2009 Jul;47(7 Suppl 1):S56-63. doi: 10.1097/MLR.0b013e3181a4f482.

PMID:
19536010
6.

Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.

Lee PP, Kelly SP, Mills RP, Traverso CE, Walt JG, Doyle JJ, Katz LM, Siegartel LR; Costs of Glaucoma Study Group..

J Glaucoma. 2007 Aug;16(5):471-8.

PMID:
17700290
7.

The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009.

Quigley HA, Cassard SD, Gower EW, Ramulu PY, Jampel HD, Friedman DS.

Ophthalmology. 2013 Nov;120(11):2249-57. doi: 10.1016/j.ophtha.2013.04.027. Epub 2013 Jun 12.

PMID:
23769330
8.

The economic burden of major adult visual disorders in the United States.

Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J.

Arch Ophthalmol. 2006 Dec;124(12):1754-60. Erratum in: Arch Ophthalmol. 2007 Sep;125(9):1304.

PMID:
17159036
9.

Cost-effectiveness of treating ocular hypertension.

Stewart WC, Stewart JA, Nasser QJ, Mychaskiw MA.

Ophthalmology. 2008 Jan;115(1):94-8. doi: 10.1016/j.ophtha.2007.01.040. Erratum in: Ophthalmology. 2008 Sep;115(9):1524. Nassar, Qasiem J [corrected to Nasser, Qasiem J].

PMID:
18166406
11.
12.

Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.

Kobelt G, J├Ânsson L, Gerdtham U, Krieglstein GK.

Graefes Arch Clin Exp Ophthalmol. 1998 Nov;236(11):811-21.

PMID:
9825256
13.
14.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
15.

Medical care cost of Medicare/Medicaid beneficiaries with vision loss.

Morse AR, Pyenson BS.

Ophthalmic Epidemiol. 2009 Jan-Feb;16(1):50-7. doi: 10.1080/09286580802523107.

PMID:
19191182
16.
17.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association..

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
18.

Economic costs of diabetes in the US in 2002.

Hogan P, Dall T, Nikolov P; American Diabetes Association..

Diabetes Care. 2003 Mar;26(3):917-32.

PMID:
12610059
19.
20.

Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.

Iskedjian M, Walker J, Vicente C, Trope GE, Buys Y, Einarson TR, Covert D.

J Glaucoma. 2003 Dec;12(6):456-62.

PMID:
14646678

Supplemental Content

Support Center